Back

Galectin-3 as a possible marker for increased thrombogenicity in COVID-19

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: COVID-19 and cardiovascular disease in special populations Autoimmune/Chronic Inflammatory Disorders and Heart Disease ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Mrs Marianna Puccini

Charite University Hospital, Berlin (Germany)

5 More presentations in this session

Presentation thumbnail
COVID-19 vaccine-induced myocarditis vs. Immune checkpoint inhibitor-induced myocarditis - Same but different?
Doctor M. Laufer-Perl (Tel Aviv, IL)
Abstract Slides
Presentation thumbnail
Impaired endothelial glycocalyx, vascular dysfunction and myocardial deformation four months after COVID-19 infection are partially improved at twelve months.
Doctor I. Ikonomidis (Athens, GR)
Abstract Slides
Presentation thumbnail
Predictors and clinical consequences of heart damage in CMR in patients after COVID-19
Doctor M. Chudzik (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Parameters of coagulation and platelet hyperreactivity reflect an increased mortality in patients with moderate to severe COVID-19
Mr K. Jakobs (Berlin, DE)
Abstract Slides
Presentation thumbnail
Pragmatic observations from a post-Covid-19 cardiac evaluation register: prevalence of cardiological alterations from a basic diagnostic sequence and contribution of the clinical hystory.
Doctor G. Ruiz (Buenos Aires, AR)
Abstract Slides

Access the full session

Session thumbnail
COVID-19 and cardiovascular disease in special populations

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources